Short answer · Medically reviewed summary · Last updated: 2026-04-07
The ICD-10 code for Urticaria pigmentosa is Q82.2, which classifies it under mastocytosis, while the older ICD-9 code is 757.33. Urticaria pigmentosa is the most common form of cutaneous mastocytosis, characterized by brown or reddish-brown skin lesions that arise from an abnormal accumulation of mast cells. What is the clinical definition of Urticaria pigmentosa? Urticaria pigmentosa is a rare skin condition belonging to the spectrum of mastocytosis.
The ICD-10 code for Urticaria pigmentosa is Q82.2, which classifies it under mastocytosis, while the older ICD-9 code is 757.33. Urticaria pigmentosa is the most common form of cutaneous mastocytosis, characterized by brown or reddish-brown skin lesions that arise from an abnormal accumulation of mast cells.
Urticaria pigmentosa is a rare skin condition belonging to the spectrum of mastocytosis. It occurs due to an infiltration of mast cells into the skin, which can release mediators such as histamine, heparin, and tryptase when triggered. These lesions typically appear as macules or papules that may urticate (hump up and become itchy) when rubbed, a phenomenon known as Darier’s sign. While Urticaria pigmentosa is often diagnosed in early childhood, it can persist into adulthood, requiring ongoing clinical management to track potential systemic involvement.
Diagnosis of Urticaria pigmentosa is primarily clinical, often confirmed through a skin biopsy that reveals increased mast cell density in the dermis. From a billing and medical record perspective, clinicians use the ICD-10 code Q82.2 to document the condition. Historically, the ICD-9 code 757.33 was utilized. It is important for patients to ensure their medical records reflect the specific subtype of mastocytosis, as Urticaria pigmentosa is distinct from more aggressive systemic forms of the disease. At DiseaseMaps.org, we have seen 84 people with Urticaria pigmentosa join our community, highlighting the importance of accurate diagnostic coding for patient advocacy and research.
Managing Urticaria pigmentosa involves identifying and avoiding specific triggers that cause mast cell degranulation. While every patient’s experience is unique, common triggers often include physical stimuli or chemical exposures. The following list outlines common considerations for patients:
In the vast majority of cases, Urticaria pigmentosa is not considered a hereditary condition. It is most frequently associated with somatic mutations in the KIT gene (most commonly D816V), which occur after conception rather than being passed down from parents. Because these mutations arise sporadically, genetic counseling can provide significant reassurance to families worried about the risk to future children.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.